We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




60-Second MRI Test Helps More Easily Diagnose Shunt Failure in Children with Hydrocephalus

By MedImaging International staff writers
Posted on 09 Feb 2024
Image: The new MRI test could transform shunt failure diagnosis in hydrocephalusy (Photo courtesy of 123RF)
Image: The new MRI test could transform shunt failure diagnosis in hydrocephalusy (Photo courtesy of 123RF)

Hydrocephalus, a condition characterized by the buildup of cerebrospinal fluid (CSF) in the brain, is commonly treated by surgically placing a shunt to drain excess fluid to another body part. While shunts are vital for managing hydrocephalus, they can sometimes malfunction, posing serious risks. The primary indicator of a shunt's effectiveness is the flow of fluid through it; a decline in flow suggests the onset of shunt failure. However, accurately diagnosing shunt failure remains a challenge, as there is no definitive test for it. Current methods, such as MRI to check for enlarged brain ventricles, shunt taps, and nuclear medicine studies, are often invasive, painful, or involve radiation exposure, and still, they do not precisely measure the fluid flow through the shunt.

Now, researchers at Children’s Hospital Los Angeles (Los Angeles, CA, USA;) have developed a 60-second MRI test that could significantly enhance the diagnosis of shunt failure in children with hydrocephalus. This test, already being implemented in clinical settings at CHLA, has the potential to improve patient care and foster research advancements. The team, comprising neurosurgeons, radiologists, biomedical engineers, and MRI physicists, utilized phase-contrast MRI, a well-established technology, to tailor an MRI sequence specifically for this purpose, which was then thoroughly tested and validated. Although shunt taps are still the clinical standard, this new MRI test could potentially replace nuclear medicine tests in some scenarios.

This innovative test can complement standard care for children undergoing evaluation for potential shunt failure. It only adds an extra minute to the usual MRI procedure. By providing more accurate diagnoses of shunt failure, the test not only offers families greater reassurance but also helps prevent unnecessary nuclear medicine tests or surgeries. It could enable earlier diagnosis of shunt issues, averting emergencies for children and their families. Additionally, the test opens new research avenues into shunt flow physiology, such as determining optimal flow values for children and designing shunts to maximize efficiency. The team is planning a national, multicenter clinical trial and conducting studies to understand how various factors, like diet and exercise, influence CSF production.

Related Links:
Children’s Hospital Los Angeles

Post-Processing Imaging System
DynaCAD Prostate
Ultrasound Table
Women’s Ultrasound EA Table
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices
Half Apron
Demi

Channels

General/Advanced Imaging

view channel
Image: The study developed a marker based on the analysis of routine CT scans of gastric cancer patients treated at UNICAMP. Higher radiodensity values for adipose tissue are linked to a worse prognosis. In contrast, higher values for muscle are linked to a more favorable outcome (Photo courtesy of FCM-UNICAMP)

CT-Derived Biomarker Predicts Outcomes in Gastric Cancer

Gastric cancer, also known as stomach cancer, is the fifth most common malignancy worldwide and often shows heterogeneous outcomes even within the same stage. Prognostic estimates typically rely on tumor-centric... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.